$IDT
IDT CORP Stock $idt

$idt Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000149315224049468 Filed on December 10, 2024

Income Statement

Concept	2024 Q4	2023 Q4
Revenue	$309.6M	$301.2M
YoY Change	2.78%	-6.4%
Cost Of Revenue	$201.9M	$206.8M
YoY Change	-2.34%	-10.73%
Gross Profit	$107.6M	$94.43M
YoY Change	13.98%	4.71%
Gross Profit Margin	34.77%	31.35%
Selling, General & Admin	$71.05M	$77.22M
YoY Change	-7.99%	17.24%
% of Gross Profit	66.02%	81.78%
Research & Development	$12.76M	$12.41M
YoY Change	2.81%
% of Gross Profit	11.85%	13.14%
Depreciation & Amortization		$5.047M
YoY Change		5.37%
% of Gross Profit		5.34%
Operating Expenses	$83.99M	$77.26M
YoY Change	8.7%	10.61%
Operating Profit	$23.64M	$17.17M
YoY Change	37.72%	-15.55%
Interest Expense		-$4.584M
YoY Change		-1000.59%
% of Operating Profit		-26.71%
Other Income/Expense, Net	-$283.0K	-$5.586M
YoY Change	-94.93%	45.39%
Pretax Income	$24.79M	$12.42M
YoY Change	99.51%	-26.46%
Income Tax	$6.302M	$3.947M
% Of Pretax Income	25.43%	31.77%
Net Earnings	$17.25M	$7.659M
YoY Change	125.21%	-30.39%
Net Earnings / Revenue	5.57%	2.54%
Basic Earnings Per Share	$0.68	$0.30
Diluted Earnings Per Share	$0.68	$0.30
COMMON SHARES
Basic Shares Outstanding	25.20M shares	25.18M shares
Diluted Shares Outstanding	25.36M shares	25.28M shares

Balance Sheet

Concept	2024 Q4	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments		$159.7M
YoY Change		16.48%
Cash & Equivalents	$148.0M	$121.7M
Short-Term Investments		$38.00M
Other Short-Term Assets	$24.63M	$27.03M
YoY Change	-8.9%	-83.73%
Inventory
Prepaid Expenses	$12.69M	$19.50M
Receivables		$35.33M
Other Receivables		$0.00
Total Short-Term Assets	$431.7M	$382.2M
YoY Change	12.96%	5.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$38.94M	$38.80M
YoY Change	0.37%	-12.14%
Goodwill	$26.31M	$26.31M
YoY Change	-0.01%	0.23%
Intangibles
YoY Change
Long-Term Investments		$8.150M
YoY Change		17.84%
Other Assets	$12.00M	$10.94M
YoY Change	9.6%	-74.66%
Total Long-Term Assets	$122.9M	$116.9M
YoY Change	5.17%	-9.83%
TOTAL ASSETS
Total Short-Term Assets	$431.7M	$382.2M
Total Long-Term Assets	$122.9M	$116.9M
Total Assets	$554.6M	$499.0M
YoY Change	11.14%	1.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$23.65M	$24.47M
YoY Change	-3.36%	-22.74%
Accrued Expenses	$92.82M	$100.1M
YoY Change	-7.28%	-6.77%
Deferred Revenue	$29.32M	$34.04M
YoY Change	-13.87%	-3.79%
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$269.8M	$275.9M
YoY Change	-2.21%	-5.75%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities	$1.058M	$3.220M
YoY Change	-67.14%	-64.9%
Total Long-Term Liabilities	$1.058M	$3.220M
YoY Change	-67.14%	-64.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$269.8M	$275.9M
Total Long-Term Liabilities	$1.058M	$3.220M
Total Liabilities	$272.4M	$281.5M
YoY Change	-3.22%	-11.09%
SHAREHOLDERS EQUITY
Retained Earnings	$102.6M	$32.32M
YoY Change	217.34%	-769.45%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$128.5M	$118.3M
YoY Change	8.62%	10.67%
Treasury Stock Shares
Shareholders Equity	$260.6M	$200.0M
YoY Change
Total Liabilities & Shareholders Equity	$554.6M	$499.0M
YoY Change	11.14%	1.7%

Cashflow Statement

Concept	2024 Q4	2023 Q4
OPERATING ACTIVITIES
Net Income	$17.25M	$7.659M
YoY Change	125.21%	-30.39%
Depreciation, Depletion And Amortization		$5.047M
YoY Change		5.37%
Cash From Operating Activities	$164.0K	$14.79M
YoY Change	-98.89%	-18.66%
INVESTING ACTIVITIES
Capital Expenditures	$5.278M	$4.322M
YoY Change	22.12%	-183.57%
Acquisitions
YoY Change
Other Investing Activities		$8.645M
YoY Change		-8.17%
Cash From Investing Activities	-$8.742M	$4.323M
YoY Change	-302.22%	1.91%
FINANCING ACTIVITIES
Cash Dividend Paid	$1.261M
YoY Change
Common Stock Issuance & Retirement, Net	$2.432M	$2.851M
YoY Change	-14.7%	-153.38%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$3.693M	-$2.649M
YoY Change	39.41%	-62.46%
NET CHANGE
Cash From Operating Activities	$164.0K	$14.79M
Cash From Investing Activities	-$8.742M	$4.323M
Cash From Financing Activities	-$3.693M	-$2.649M
Net Change In Cash	-$12.24M	$9.630M
YoY Change	-227.13%	-37.35%
FREE CASH FLOW
Cash From Operating Activities	$164.0K	$14.79M
Capital Expenditures	$5.278M	$4.322M
Free Cash Flow	-$5.114M	$10.47M
YoY Change	-148.85%	-55.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--07-31
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q4	dei	Document Type DocumentType	10-Q
CY2024Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	164557000	usd
CY2024Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	95194000	usd
CY2024Q4	us-gaap	Debt Securities Current DebtSecuritiesCurrent	27274000	usd
CY2024Q3	us-gaap	Debt Securities Current DebtSecuritiesCurrent	23438000	usd
CY2024Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	5071000	usd
CY2024Q3	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	5009000	usd
CY2024Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6634000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6352000	usd
CY2024Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	41566000	usd
CY2024Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	42215000	usd
CY2024Q4	IDT	Settlement Assets Reserve SettlementAssetsReserve	1903000	usd
CY2024Q3	IDT	Settlement Assets Reserve SettlementAssetsReserve	1866000	usd
CY2024Q4	us-gaap	Settlement Assets Current SettlementAssetsCurrent	25245000	usd
CY2024Q3	us-gaap	Settlement Assets Current SettlementAssetsCurrent	22186000	usd
CY2024Q4	IDT	Disbursement Prefunding DisbursementPrefunding	52041000	usd
CY2024Q3	IDT	Disbursement Prefunding DisbursementPrefunding	30736000	usd
CY2024Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	12686000	usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	17558000	usd
CY2024Q4	us-gaap	Other Assets Current OtherAssetsCurrent	24627000	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	25927000	usd
CY2024Q4	us-gaap	Assets Current AssetsCurrent	431723000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	422525000	usd
CY2024Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	38944000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	38652000	usd
CY2024Q4	us-gaap	Goodwill Goodwill	26309000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	26288000	usd
CY2024Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	5947000	usd
CY2024Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	6285000	usd
CY2024Q4	us-gaap	Long Term Investments LongTermInvestments	7092000	usd
CY2024Q3	us-gaap	Long Term Investments LongTermInvestments	6518000	usd
CY2024Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3101000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3273000	usd
CY2024Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	29523000	usd
CY2024Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	35008000	usd
CY2024Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11995000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11546000	usd
CY2024Q4	us-gaap	Assets Assets	554634000	usd
CY2024Q3	us-gaap	Assets Assets	550095000	usd
CY2024Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	23647000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	24773000	usd
CY2024Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	92821000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	103176000	usd
CY2024Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	29321000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	30364000	usd
CY2024Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	94951000	usd
CY2024Q3	us-gaap	Deposit Liability Current DepositLiabilityCurrent	91893000	usd
CY2024Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	12710000	usd
CY2024Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	16373000	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	16374000	usd
CY2024Q4	us-gaap	Liabilities Current LiabilitiesCurrent	269823000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	279344000	usd
CY2024Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1566000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1533000	usd
CY2024Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1058000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2662000	usd
CY2024Q4	us-gaap	Liabilities Liabilities	272447000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	283539000	usd
CY2024Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	11039000	usd
CY2024Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	10901000	usd
CY2024Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q4	dei	Entity File Number EntityFileNumber	1-16371
CY2024Q4	dei	Entity Registrant Name EntityRegistrantName	IDT CORPORATION
CY2024Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-3415036
CY2024Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	520 Broad Street
CY2024Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	Newark
CY2024Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2024Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07102
CY2024Q4	dei	City Area Code CityAreaCode	(973)
CY2024Q4	dei	Local Phone Number LocalPhoneNumber	438-1000
CY2024Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q4	dei	Entity Central Index Key EntityCentralIndexKey	0001005731
CY2024Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet		usd
CY2023Q4	us-gaap	Payments Of Dividends PaymentsOfDividends		usd
CY2024Q4	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders		usd
CY2024Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther		usd
CY2024Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P0Y
CY2024Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P0Y
CY2024Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2024Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2024Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount		usd
CY2024Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount		usd
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount		usd
CY2023Q4	IDT	Equity Securities Fv Ni Recognized Gain Loss Net On Equity Securities Redeemed EquitySecuritiesFvNiRecognizedGainLossNetOnEquitySecuritiesRedeemed		usd
CY2024Q4	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2024#NonoperatingIncomeExpense
CY2023Q4	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2024#NonoperatingIncomeExpense
CY2024Q4	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss		usd
CY2023Q4	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss		usd
CY2024Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements		usd
CY2024Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome		usd
CY2024Q4	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Other Comprehensive Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
CY2023Q4	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Other Comprehensive Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
CY2024Q4	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss		usd
CY2023Q4	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss		usd
CY2024Q4	us-gaap	Legal Fees LegalFees		usd
CY2024Q4	us-gaap	Unusual Or Infrequent Item Insurance Proceeds UnusualOrInfrequentItemInsuranceProceeds		usd
CY2024Q4	IDT	Corporate Other CorporateOther		usd
CY2024Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet		usd
CY2024Q4	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2024Q4	dei	Document Period End Date DocumentPeriodEndDate	2024-10-31
CY2024Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q4	dei	Security12b Title Security12bTitle	Class B common stock, par value $.01 per share
CY2024Q4	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2024Q4	dei	Trading Symbol TradingSymbol	IDT
CY2024Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q4	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2024Q4	dei	Entity Small Business EntitySmallBusiness	false
CY2024Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q4	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	148019000	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	90899000	usd
CY2024Q3	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	12764000	usd
CY2024Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	305918000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	303510000	usd
CY2024Q4	us-gaap	Treasury Stock Value TreasuryStockValue	128512000	usd
CY2024Q3	us-gaap	Treasury Stock Value TreasuryStockValue	126080000	usd
CY2024Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-19709000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-18142000	usd
CY2024Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	102568000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	86580000	usd
CY2024Q4	us-gaap	Stockholders Equity StockholdersEquity	260580000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	246183000	usd
CY2024Q4	us-gaap	Minority Interest MinorityInterest	10568000	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	9472000	usd
CY2024Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	271148000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	255655000	usd
CY2024Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	554634000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	550095000	usd
CY2024Q4	us-gaap	Revenues Revenues	309566000	usd
CY2023Q4	us-gaap	Revenues Revenues	301205000	usd
CY2024Q4	us-gaap	Cost Of Revenue CostOfRevenue	201939000	usd
CY2023Q4	us-gaap	Cost Of Revenue CostOfRevenue	207211000	usd
CY2024Q4	us-gaap	Gross Profit GrossProfit	107627000	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	93994000	usd
CY2024Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	71051000	usd
CY2023Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	64378000	usd
CY2024Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12759000	usd
CY2023Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12410000	usd
CY2024Q4	us-gaap	Severance Costs1 SeveranceCosts1	177000	usd
CY2023Q4	us-gaap	Severance Costs1 SeveranceCosts1	525000	usd
CY2023Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	484000	usd
CY2024Q4	us-gaap	Operating Expenses OperatingExpenses	83987000	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	76829000	usd
CY2024Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	23640000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	17165000	usd
CY2024Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1428000	usd
CY2023Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	844000	usd
CY2024Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-283000	usd
CY2023Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5586000	usd
CY2024Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	24785000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	12423000	usd
CY2024Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6302000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3947000	usd
CY2024Q4	us-gaap	Profit Loss ProfitLoss	18483000	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	8476000	usd
CY2024Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1234000	usd
CY2023Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	817000	usd
CY2024Q4	us-gaap	Net Income Loss NetIncomeLoss	17249000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	7659000	usd
CY2024Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.68
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.30
CY2024Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.68
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
CY2024Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25204000	shares
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25178000	shares
CY2024Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25363000	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25277000	shares
CY2024Q4	us-gaap	Profit Loss ProfitLoss	18483000	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	8476000	usd
CY2024Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	56000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-66000	usd
CY2024Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1623000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	631000	usd
CY2024Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1567000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	565000	usd
CY2024Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	16916000	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	9041000	usd
CY2024Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1234000	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	817000	usd
CY2024Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	15682000	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8224000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	255655000	usd
CY2024Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05
CY2024Q4	us-gaap	Dividends Common Stock DividendsCommonStock	1261000	usd
CY2024Q4	IDT	Treasury Stock Value Repurchases Of Common Stock Through Repurchase Program TreasuryStockValueRepurchasesOfCommonStockThroughRepurchaseProgram	-1339000	usd
CY2024Q4	IDT	Treasury Stock Value Restricted Common Stock Purchased From Employees TreasuryStockValueRestrictedCommonStockPurchasedFromEmployees	-1093000	usd
CY2024Q4	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	1824000	usd
CY2024Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	584000	usd
CY2024Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1567000	usd
CY2024Q4	IDT	Net Income Loss Including Portion Attributable To Redeemable Non Controlling Interest And Non Controlling Interest In Subsidiaries NetIncomeLossIncludingPortionAttributableToRedeemableNonControllingInterestAndNonControllingInterestInSubsidiaries	18345000	usd
CY2024Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	271148000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	199996000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	199996000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	172000	usd
CY2023Q4	IDT	Treasury Stock Value Repurchases Of Common Stock Through Repurchase Program TreasuryStockValueRepurchasesOfCommonStockThroughRepurchaseProgram	-2836000	usd
CY2023Q4	IDT	Treasury Stock Value Restricted Common Stock Purchased From Employees TreasuryStockValueRestrictedCommonStockPurchasedFromEmployees	-15000	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	771000	usd
CY2023Q4	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	55000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	565000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	565000	usd
CY2023Q4	IDT	Net Income Loss Including Portion Attributable To Redeemable Non Controlling Interest And Non Controlling Interest In Subsidiaries NetIncomeLossIncludingPortionAttributableToRedeemableNonControllingInterestAndNonControllingInterestInSubsidiaries	8369000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	206967000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	206967000	usd
CY2024Q4	us-gaap	Profit Loss ProfitLoss	18483000	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	8476000	usd
CY2024Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5241000	usd
CY2023Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5047000	usd
CY2024Q4	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	5485000	usd
CY2023Q4	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	3561000	usd
CY2024Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1002000	usd
CY2023Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	759000	usd
CY2024Q4	us-gaap	Share Based Compensation ShareBasedCompensation	912000	usd
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	771000	usd
CY2024Q4	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-692000	usd
CY2023Q4	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2425000	usd
CY2024Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	200000	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4572000	usd
CY2024Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	20380000	usd
CY2023Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-8250000	usd
CY2024Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-12771000	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-6285000	usd
CY2024Q4	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	2810000	usd
CY2023Q4	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-3017000	usd
CY2024Q4	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1110000	usd
CY2023Q4	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-540000	usd
CY2024Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	164000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	14875000	usd
CY2024Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5278000	usd
CY2023Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4322000	usd
CY2024Q4	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	673000	usd
CY2023Q4	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	672000	usd
CY2024Q4	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	12669000	usd
CY2023Q4	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	7750000	usd
CY2024Q4	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	9878000	usd
CY2023Q4	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	17067000	usd
CY2024Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8742000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4323000	usd
CY2024Q4	us-gaap	Payments Of Dividends PaymentsOfDividends	1261000	usd
CY2023Q4	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	55000	usd
CY2024Q4	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	14243000	usd
CY2023Q4	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	30315000	usd
CY2024Q4	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	14243000	usd
CY2023Q4	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	30315000	usd
CY2023Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	172000	usd
CY2024Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2432000	usd
CY2023Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2851000	usd
CY2024Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3693000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2734000	usd
CY2024Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28000	usd
CY2023Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-6834000	usd
CY2024Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-12243000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9630000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	255456000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	198823000	usd
CY2024Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	243213000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208453000	usd
CY2024Q4	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	1824000	usd
CY2024Q4	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_841_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zfA9G5VxSKX5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zIf7aA35Rqsc">Reclassifications</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">From and after August 1, 2024, the Company reclassified certain customer funds for pending money transfers in its consolidated financial statements. In the consolidated balance sheet at July 31, 2024, $<span id="xdx_90B_eus-gaap--SettlementLiabilitiesCurrent_iI_pn5n6_c20240731__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zEaXbE2WSsVf" title="Settlement liabilities">8.9</span> million previously included in “Settlement liabilities” was reclassified to “Customer funds deposits,” and in the consolidated statements of cash flows in the three months ended October 31, 2023, cash used for “Trade accounts payable, accrued expenses, settlement liabilities, other current liabilities, and other liabilities” of $<span id="xdx_907_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_pn5n6_c20230801__20231031__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zvel8jM4EtHi" title="Customer funds deposits">0.7</span> million was reclassified to cash used for “Customer funds deposits”. These amounts were reclassified to conform to the current year’s presentation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From and after February 1, 2024, the Company reclassified most of its technology and development expenses from “Selling, general and administrative” expense to a new “Technology and development” expense caption in the consolidated statements of income and reclassified an amount that was immaterial in all periods to “Direct cost of revenues.” The following table shows the amounts that were reclassified in the three months ended October 31, 2023 to conform to the current period’s presentation:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zWwcZQG94Jhh" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_z9JvzkbiMJxh">Schedule of Amount that were Reclassified</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20240801__20241031_zJO62zg0J9wj" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>(in thousands)</b></span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Selling, general and administrative expense reclassified to:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--SellingGeneralAndAdministrativeExpense_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__srt--ProductOrServiceAxis__custom--DirectCostofRevenuesMember_z5my8uBtlpm4" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 80%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Direct cost of revenues</span></td><td style="width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">434</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--SellingGeneralAndAdministrativeExpense_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__srt--ProductOrServiceAxis__custom--TechnologyAndDevelopmentExpenseMember_zsAhJJ4oIyz9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Technology and development expenses</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,410</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--SellingGeneralAndAdministrativeExpense_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__srt--ProductOrServiceAxis__custom--TechnologyAndDevelopmentExpenseMember_zsUpfxDfKIVj" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Selling, general and administrative expense</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,410</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segments
CY2024Q4	us-gaap	Revenues Revenues	309566000	usd
CY2024Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	23640000	usd
CY2024Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5241000	usd
CY2023Q4	us-gaap	Revenues Revenues	301205000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	17165000	usd
CY2023Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5047000	usd
CY2024Q4	us-gaap	Revenues Revenues	309566000	usd
CY2023Q4	us-gaap	Revenues Revenues	301205000	usd
CY2024Q4	us-gaap	Revenues Revenues	309566000	usd
CY2023Q4	us-gaap	Revenues Revenues	301205000	usd
CY2024Q4	us-gaap	Revenues Revenues	309566000	usd
CY2023Q4	us-gaap	Revenues Revenues	301205000	usd
CY2023Q4	us-gaap	Revenues Revenues	301205000	usd
CY2024Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	46319000	usd
CY2024Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	24838000	usd
CY2024Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	12829000	usd
CY2024Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	83986000	usd
CY2024Q4	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	13600000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	16089000	usd
CY2024Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	4948000	usd
CY2024Q3	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	4823000	usd
CY2024Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	4549000	usd
CY2024Q3	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	4276000	usd
CY2024Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	9497000	usd
CY2024Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	9099000	usd
CY2024Q4	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1498000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1215000	usd
CY2024Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	601000	usd
CY2023Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	758000	usd
CY2024Q4	us-gaap	Short Term Lease Cost ShortTermLeaseCost	258000	usd
CY2023Q4	us-gaap	Short Term Lease Cost ShortTermLeaseCost	326000	usd
CY2024Q4	us-gaap	Lease Cost LeaseCost	859000	usd
CY2023Q4	us-gaap	Lease Cost LeaseCost	1084000	usd
CY2024Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	614000	usd
CY2023Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	791000	usd
CY2024Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	614000	usd
CY2023Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	791000	usd
CY2024Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M6D
CY2024Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.057	pure
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.056	pure
CY2024Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	400000	usd
CY2023Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	100000	usd
CY2024Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1640000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1866000	usd
CY2024Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1566000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1533000	usd
CY2024Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3206000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	3399000	usd
CY2024Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	1768000	usd
CY2024Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	801000	usd
CY2024Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	500000	usd
CY2024Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	198000	usd
CY2024Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive	186000	usd
CY2024Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive	15000	usd
CY2024Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3468000	usd
CY2024Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	262000	usd
CY2024Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3206000	usd
CY2024Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	148019000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	164557000	usd
CY2024Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	95194000	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	90899000	usd
CY2024Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	243213000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	255456000	usd
CY2024Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	95194000	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	90899000	usd
CY2024Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	27598000	usd
CY2024Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	18000	usd
CY2024Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	342000	usd
CY2024Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	27274000	usd
CY2024Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	23818000	usd
CY2024Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	11000	usd
CY2024Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	391000	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	23438000	usd
CY2024Q4	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	9900000	usd
CY2023Q4	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	17100000	usd
CY2024Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	20752000	usd
CY2024Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	5562000	usd
CY2024Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	923000	usd
CY2024Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	37000	usd
CY2024Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	27274000	usd
CY2024Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	342000	usd
CY2024Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	15195000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	391000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	18880000	usd
CY2024Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	317000	usd
CY2024Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	5414000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	367000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	8036000	usd
CY2024Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	5071000	usd
CY2024Q3	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	5009000	usd
CY2024Q4	us-gaap	Long Term Investments LongTermInvestments	7092000	usd
CY2024Q3	us-gaap	Long Term Investments LongTermInvestments	6518000	usd
CY2016Q2	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	1830	shares
CY2024Q3	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	964000	usd
CY2023Q3	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	1632000	usd
CY2024Q4	IDT	Adjustment For Observable Transactions Involving Similar Investment From Same Issuer AdjustmentForObservableTransactionsInvolvingSimilarInvestmentFromSameIssuer	63000	usd
CY2023Q4	IDT	Adjustment For Observable Transactions Involving Similar Investment From Same Issuer AdjustmentForObservableTransactionsInvolvingSimilarInvestmentFromSameIssuer	-14000	usd
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount	129000	usd
CY2024Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	1027000	usd
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	1747000	usd
CY2024Q4	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	378000	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-917000	usd
CY2024Q4	IDT	Equity Securities Fv Ni Recognized Gain Loss Net On Equity Securities Redeemed EquitySecuritiesFvNiRecognizedGainLossNetOnEquitySecuritiesRedeemed	2000	usd
CY2024Q4	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	380000	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-917000	usd
CY2024Q4	us-gaap	Equity Method Investment Difference Between Carrying Amount And Underlying Equity EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity	8200000	usd
CY2024Q4	us-gaap	Equity Method Investment Difference Between Carrying Amount And Underlying Equity Accounting Treatment EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquityAccountingTreatment	These basis differences are being amortized over the 6-year estimated life of the customer list.
CY2024Q4	IDT	Investment In Hedge Funds InvestmentInHedgeFunds	2900000	usd
CY2024Q3	IDT	Investment In Hedge Funds InvestmentInHedgeFunds	2900000	usd
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	695000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1263000	usd
CY2024Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	63000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	-14000	usd
CY2024Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	758000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1249000	usd
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	906000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4805000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-214000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome	-3000	usd
CY2024Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	906000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4588000	usd
CY2023Q4	us-gaap	Payment For Contingent Consideration Liability Investing Activities PaymentForContingentConsiderationLiabilityInvestingActivities	200000	usd
CY2024Q4	IDT	Variable Interest Entity Net Income Losst Amount VariableInterestEntityNetIncomeLosstAmount	338000	usd
CY2023Q4	IDT	Variable Interest Entity Net Income Losst Amount VariableInterestEntityNetIncomeLosstAmount	81000	usd
CY2024Q4	IDT	Variable Interest Entity Aggregate Funding Repaid To Provided By Reporting Entity VariableInterestEntityAggregateFundingRepaidToProvidedByReportingEntity	55000	usd
CY2023Q4	IDT	Variable Interest Entity Aggregate Funding Repaid To Provided By Reporting Entity VariableInterestEntityAggregateFundingRepaidToProvidedByReportingEntity	114000	usd
CY2023Q4	us-gaap	Legal Fees LegalFees	212000	usd
CY2023Q4	us-gaap	Unusual Or Infrequent Item Insurance Proceeds UnusualOrInfrequentItemInsuranceProceeds	684000	usd
CY2023Q4	IDT	Corporate Other CorporateOther	-12000	usd
CY2023Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	484000	usd
CY2024Q4	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	4400000	shares
CY2024Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25204000	shares
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25178000	shares
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	3000	shares
CY2024Q4	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	159000	shares
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	96000	shares
CY2024Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25363000	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25277000	shares
CY2024Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2023Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-18142000	usd
CY2024Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1567000	usd
CY2024Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-19709000	usd
CY2024Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	24400000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	25900000	usd
CY2024Q4	us-gaap	Purchase Obligation PurchaseObligation	1300000	usd
CY2024Q4	IDT	Performance Bonds Outstanding PerformanceBondsOutstanding	33200000	usd
CY2024Q3	IDT	Performance Bonds Outstanding PerformanceBondsOutstanding	32400000	usd
CY2024Q4	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	135000	usd
CY2023Q4	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-3499000	usd
CY2024Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-780000	usd
CY2023Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1012000	usd
CY2024Q4	us-gaap	Gain Loss On Investments GainLossOnInvestments	378000	usd
CY2023Q4	us-gaap	Gain Loss On Investments GainLossOnInvestments	-917000	usd
CY2024Q4	us-gaap	Other Income OtherIncome	-16000	usd
CY2023Q4	us-gaap	Other Income OtherIncome	-158000	usd
CY2024Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-283000	usd
CY2023Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5586000	usd
CY2024Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.254	pure
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.282	pure
CY2024Q4	IDT	No Insider Trading Flag NoInsiderTradingFlag	true

Files In Submission

Name	View Source	Status
0001493152-24-049468-index-headers.html	Edgar Link	pending
0001493152-24-049468-index.html	Edgar Link	pending
0001493152-24-049468.txt	Edgar Link	pending
0001493152-24-049468-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
idt-20241031.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
idt-20241031_cal.xml	Edgar Link	unprocessable
idt-20241031_lab.xml	Edgar Link	unprocessable
idt-20241031_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
idt-20241031_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IDT
IDT CORP Stock $idt

2024 Q4 Form 10-Q Financial Statement

#000149315224049468 Filed on December 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IDT IDT CORP Stock $idt

2024 Q4 Form 10-Q Financial Statement

#000149315224049468 Filed on December 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IDT
IDT CORP Stock $idt